Abstract
Corynoline, an isoquinoline alkaloid isolated from the genus Corydalis, has been demonstrated to show multiple pharmacological effects including inhibition of acetylcholinesterase, inhibition of cell adhesion, fungitoxic and cytotoxic activity. The present study focused on its metabolism and metabolism-based herb-drug interactions. After corynoline was incubated with human liver microsomes (HLMs) in the presence of NADPH, two metabolites (M-1 and M-2) were formed. Chemical inhibition experiments and assays with recombinant CYP isoforms showed that CYP2C9 was mainly involved in the formation of M-1 and CYP3A4 mainly catalysed the production of M-2. Among seven major CYP isoforms tested, corynoline showed strong inhibitory effects on the activities of CYP3A4 and CYP2C9, with an IC(50) of 3.3 ± 0.9 µm and 31.5 ± 0.5 µm, respectively. Kinetic analysis showed that inhibition of CYP3A4 by corynoline was best fit to a noncompetitive manner with K(i) of 3.2 µm, while inhibition of CYP2C9 by corynoline was best fit to a competitive manner with K(i) of 6.3 µm. Additionally, corynoline exhibited time-dependent inhibition (TDI) toward CYP3A4. The inactivation kinetic parameters (K(I) and k(inact) ) were calculated to be 6.8 µm and 0.07 min...Continue Reading
References
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·W W MederskiC Wilm
Jul 27, 2001·Current Drug Metabolism·M Murray
Oct 17, 2001·Annals of Internal Medicine·P Goldman
Apr 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·James M RaeZeruesenay Desta
Jan 4, 2003·Archives of Pharmacal Research·Dae Keun Kim
Sep 3, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hiroshi IwataTadashi Watabe
Dec 21, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert L WalskyWilliam R Proctor
Feb 9, 2005·Bioorganic & Medicinal Chemistry·Miyoko KamigauchiToshimasa Ishida
Mar 15, 2005·Clinical Pharmacokinetics·Shufeng ZhouHoward L McLeod
Nov 8, 2005·Drug Metabolism and Pharmacokinetics·Chie EmotoKazuhide Iwasaki
Apr 6, 2006·The AAPS Journal·F Peter Guengerich
Mar 21, 2007·Archives of Pharmacal Research·Sang Un ChoiDae Keun Kim
Aug 21, 2007·Drug Discovery Today·Shu-Feng ZhouAdrian Herington
Dec 7, 2007·Cancer Letters·Kedar PurnapatreKulvinder Singh Saini
Apr 8, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Y-Y ZhangL Yang
Mar 18, 2010·British Journal of Clinical Pharmacology·Zhong-Ze FangLing Yang
Citations
Apr 9, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Fahad I Al-JenoobiSaleh A Al-Suwayeh
Aug 21, 2013·BioMed Research International·F I Al-JenoobiMohd Raish
Jan 22, 2013·Fitoterapia·Ming CongJun-Sheng Luo
Jan 4, 2019·The Journal of Membrane Biology·Meishan ZhangShuqiang Liu
Jul 7, 2012·Phytotherapy Research : PTR·Hong-Zhi SunMo Hong
Nov 30, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Wei-Feng GaoChun-Ze Zhang
Aug 12, 2015·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xu MaoJiang Zheng
Dec 21, 2014·European Journal of Drug Metabolism and Pharmacokinetics·Hua-Jun Qu, Yang Qian
Nov 22, 2018·Frontiers in Pharmacology·Ruijuan LiuLi Ding
Feb 23, 2019·Biomedical Chromatography : BMC·Xu MaoJiang Zheng
Mar 16, 2013·The Journal of Pharmacy and Pharmacology·Jin-Hui SongDe-Wei Zhao
May 26, 2011·Expert Opinion on Drug Metabolism & Toxicology·Zhong-Ze FangLing Yang